Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome
Clinical trial NCT02879578 · COMPLETED
Trial details
- NCT number
- NCT02879578
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-25
- Primary completion
- 2017-11-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.